An investigation on behalf of investors in Novan, Inc. (NASDAQ:NOVN) shares over potential wrongdoing at Novan, Inc. was announced.
San Diego, CA -- (SBWIRE) -- 01/08/2021 -- An investigation on behalf of investors in shares of Novan, Inc. (NASDAQ: NOVN) was announced over potential breaches of fiduciary duties by certain directors at Novan, Inc.
Investors who purchased shares of Novan, Inc. (NASDAQ: NOVN) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Novan, Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders.
Morrisville, NC based Novan, Inc., a clinical development-stage biotechnology company, focuses on the development and commercialization of nitric oxide-based therapies to treat dermatological and oncovirus-mediated diseases. Novan, Inc. reported that its annual Total Revenue declined from $5.99 million in 2018 to $4.8 million in 2019 and that its Net Loss increased from $11.62 million in 2018 to $30.63 million in 2019.
Those who purchased shares of Novan, Inc. (NASDAQ: NOVN), have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.